Fundraising FoxHatch BioFund
Venture capitalDoylestown · Pre-Seed–Late Stage · 3 people tracked
Find your way into Hatch BioFund
384 people in our graph share verified history with the Hatch BioFund team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Hatch BioFund focuses solely on private companies creating human therapeutics and vaccines. It invests across all development stages and treatment modalities, spanning small molecules to cell and gene therapy, while favoring capital efficiency, reasonably understood disease biology, and clear development pathways. The firm prioritizes experimental medicines with strong societal value and evaluates management teams against four criteria: whether the product has a strong commercial rationale, whether the development path is known and capital-efficient, whether manufacturing can be industrialized, and whether the underlying disease biology is reasonably understood.
Source: firm website, verified Sep 29, 2026.
What founders say
No founder feedback on Hatch BioFund yet.
Team · 3 people
from the firm's website & public directories
What they invest in
from 5 of 7 portfolio companiesBiotech ×5Deep Tech ×4Healthtech ×2Medical Devices ×2AI & Machine Learning ×1
HQs:United States×4
Investments · 7 tracked
founders shown can be your intro pathBy year:2026 · 22021 · 13 dated
Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery.
BiotechDeep TechMedical DevicesBlue Bell, US
Christian Schafmeister(Founder)inEric Heil(Chief Executive Officer)in
Co-investorsMedical Excellence CapitalSmartGateVC
Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise.
AI & Machine LearningBiotechDeep TechHealthtechPhiladelphia, US
Co-investors8VCBioAdvanceDCVC (Data Collective)DCVC BioGaingelsKorea Development Bank+1 more
__Twitter.png)
MasterSwitch Bio is developing master transcription therapy aimed at rescuing end-stage organs.
Biotech
Christina Galbraith(Chief Operating Officer)
Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity.
BiotechDeep TechHealthtechPrinceton, US
Robert K. Prud'homme, PhD(Director)Bob Prud'homme(Leadership (PhD))Rob Pagels(Leadership (PhD))Chet Markwalter(Leadership (PhD))inShahram Hejazi, PhD(Executive Officer, Director)inShahram Hejazi(Leadership (PhD))in
Co-investors7G BioVenturesAnzu Partners
Vittoria develops immunotherapies, specifically CAR T-cell therapies, to treat difficult-to-treat diseases including cancers beyond B-cell types.
BiotechDeep TechMedical DevicesPhiladelphia, US
Nicholas Siciliano(Director)inPreston Noon(Executive Officer)
BoardGeeta Vemuri(Executive Officer, Director)Bruce Peacock(Executive Officer, Director)Leon Moulder(Director)
Co-investorsAgent CapitalBioAdvanceGlobal BioAccess Fund
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
HulaLadder Bio
Portfolio news
latest coverage across their companies
Optimeos-Logo-Web · finsmes.com · Jun 25, 2026
Latus · finsmes.com · May 5, 2026
Frequently asked questions
- How many investments has Hatch BioFund made?
- Hatch BioFund has 7 tracked investments, including 2 dated in the last 24 months.
- What stage does Hatch BioFund invest at?
- Hatch BioFund invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What sectors does Hatch BioFund focus on?
- Hatch BioFund focuses on Biotech.
- Where is Hatch BioFund located?
- Hatch BioFund is headquartered in Doylestown, US.
- Who does Hatch BioFund co-invest with?
- Hatch BioFund most often shares deals with BioAdvance, Agent Capital, Anzu Partners, among 7 tracked co-investors.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests in technology companies from seed to growth stage. Since inception it has backed over 200 companies and raised more than $1.3 billion.
.png)
General Catalyst is a venture capital firm operating as a partnership focused on company building and accelerating the growth of the businesses it backs.
Hummingbird Ventures is a global venture capital firm that backs outlier founders across all stages, from inception to IPO, without limiting itself to specific verticals or geographies.
Inveready is a Spanish alternative investment firm founded in 2008, offering investment solutions and wealth management services across the small and mid-market segment in Spain.